Literature DB >> 1815636

Theoretical study of ethidium intercalation in triple-stranded DNA and at triplex-duplex junctions.

J S Sun1, R Lavery, J Chomilier, K Zakrzewska, T Montenay-Garestier, C Hélène.   

Abstract

The contribution of different factors in the interaction of ethidium intercalated into various sequences of a triple helix, or in the region of the junction between the double- and triple-stranded DNA has been studied by energy minimization. It is found that in the total energy of the ethidium- triple helix complexes, a particular electrostatic contribution emerges due to the presence of protonated cytosines in the triple helix. This parameters is determinant in the sequence-specificity of ethidium binding to the triple helix. The preferred intercalation sites of ethidium in the triple helix are proposed. The interaction of ethidium at the triplex-duplex junction, and its effects are also discussed. This study is aimed at searching for new drugs specific for the triple helix, or for the triplex-duplex junctions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1815636     DOI: 10.1080/07391102.1991.10507926

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  4 in total

1.  DNA sequence specificity of a naphthylquinoline triple helix-binding ligand.

Authors:  S A Cassidy; L Strekowski; K R Fox
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

Review 2.  Impact of alternative DNA structures on DNA damage, DNA repair, and genetic instability.

Authors:  Guliang Wang; Karen M Vasquez
Journal:  DNA Repair (Amst)       Date:  2014-04-21

Review 3.  Modulation of DNA structure formation using small molecules.

Authors:  Imee M A Del Mundo; Karen M Vasquez; Guliang Wang
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-09-03       Impact factor: 4.739

4.  Ligand-induced formation of nucleic acid triple helices.

Authors:  D S Pilch; K J Breslauer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.